dc.contributor.author | Hernández Marrero, Domingo Jerónimo | |
dc.contributor.author | Vázquez Sánchez, Teresa | |
dc.contributor.author | Sánchez Niño, María Dolores | |
dc.contributor.author | Ruiz Estéban, Pedro | |
dc.contributor.author | López, Veronica | |
dc.contributor.author | León, Miriam | |
dc.contributor.author | Caballero, Abelardo | |
dc.contributor.author | Ruiz Escalera, Juan Francisco | |
dc.contributor.author | Ortiz, Alberto | |
dc.contributor.author | Torres, Armando | |
dc.contributor.author | Rodríguez, Mariano | |
dc.date.accessioned | 2024-10-18T20:05:47Z | |
dc.date.available | 2024-10-18T20:05:47Z | |
dc.date.issued | 2023 | |
dc.identifier.issn | 2077-0383 | |
dc.identifier.uri | http://riull.ull.es/xmlui/handle/915/39731 | |
dc.description.abstract | We investigated the evolution of serum klotho (s-Kl) and FGF-23 during the first two years post-kidney transplantation (KT), considering the cold ischemia time (CIT), glomerular filtration rate (GFR) and graft subclinical inflammation (SCI). We undertook a prospective, cohort, multicenter Academic Editor: Magdi Yaqoob Received: 2 June 2023 Revised: 23 June 2023 Accepted: 30 June 2023 Published: 4 July 2023 Copyright: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). study of consecutive patients between April 2018 and January 2021 (with follow-up at 24 months). Subgroups were analyzed according to the median CIT (<14 vs. ≥14 h), the median GFR (≤40 vs. >40 mL/min/1.73 m2) and the presence of SCI at month 3. A total of 147 patients were included. s-Kl and fibroblast growth factor-23 (FGF-23) levels were measured at baseline and at months 3, 12 and 24. Graft biopsies (n = 96) were performed at month 3. All patients had low s-Kl levels at month 3. Patients with CIT < 14 h exhibited a significant increase in s-Kl at month 24. In patients with CIT ≥14h,s-Kl at month 3fell and lower s-Kl levels were seen at month 24. Patients with a GFR > 40 had a lesser decrease in s-Kl at month 3. FGF-23 fell significantly at months 3 and 12 in both GFR groups, a reduction maintained during follow-up. There were significant inter-group differences in s-Kl from months 3 to 24. CIT, GFR at 3 months and SCI were significantly associated with s-KI at month 3. A reduction in s-Kl at month 3 post-KT could be explained by longer CIT and delayed graft function as well as by impaired graft function. Early SCI may regulate s-Kl increase post-KT. | en |
dc.format.mimetype | application/pdf | |
dc.language.iso | en | |
dc.relation.ispartofseries | Journal of clinical medicine, vol. 12, 2023. | |
dc.rights | Licencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 Internacional) | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es_ES | |
dc.title | Time dependent changes of klotho and fgf-23 levels after kidney transplantation: role of cold ischemia time, renal function and graft inflammation. | |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | doi.org/10.3390/jcm12134486 | |
dc.subject.keyword | kidney transplant | en |
dc.subject.keyword | serum klotho levels | en |
dc.subject.keyword | serum FGF-23 levels | en |
dc.subject.keyword | graft function | en |
dc.subject.keyword | graft subclinical inflammation | en |
dc.subject.keyword | cold ischemia time | en |